Graft characteristics
| . | MAC (n = 14) . | RIC (n = 26) . |
|---|---|---|
| Graft relation to patient | ||
| Related (sibling) | 1 (7%) | 6 (23%) |
| Unrelated | 13 (93%) | 20 (77%) |
| Graft source | ||
| Bone marrow | 12 (86%) | 24 (92%) |
| Peripheral blood | 0 | 2 (8%) |
| Cord blood | 2 (14%) | 0 |
| HLA match | ||
| Full match, 8/8 (HLA A, B, and C, and DRB1) | 9 (64%) | 19 (73%) |
| Mismatch, 7/8 (HLA A, B, and C, and DRB1) | 5 (36%) | 7 (27%) |
| Graft cell dose | ||
| Average total nucleated cell dose × 108/kg | 2.9 | 6.3 |
| Median total nucleated cell dose × 108/kg (range) | 3 (0.57-3.12) | 7 (1.4-11.5) |
| . | MAC (n = 14) . | RIC (n = 26) . |
|---|---|---|
| Graft relation to patient | ||
| Related (sibling) | 1 (7%) | 6 (23%) |
| Unrelated | 13 (93%) | 20 (77%) |
| Graft source | ||
| Bone marrow | 12 (86%) | 24 (92%) |
| Peripheral blood | 0 | 2 (8%) |
| Cord blood | 2 (14%) | 0 |
| HLA match | ||
| Full match, 8/8 (HLA A, B, and C, and DRB1) | 9 (64%) | 19 (73%) |
| Mismatch, 7/8 (HLA A, B, and C, and DRB1) | 5 (36%) | 7 (27%) |
| Graft cell dose | ||
| Average total nucleated cell dose × 108/kg | 2.9 | 6.3 |
| Median total nucleated cell dose × 108/kg (range) | 3 (0.57-3.12) | 7 (1.4-11.5) |